Related Experiment Videos
[Clinical effect of cefpiramide against infectious diseases in obstetrics and gynecology]
Abstract:
Clinical study on cefpiramide (CPM, SM-1652), a new cephalosporin antibiotic, was carried out and the following results were obtained. CPM was intravenously administrated at a daily dose of 2 g to 8 cases including 2 cases with intrauterine infection, 3 cases with adnexitis, 2 cases with intrapelvic infection and 1 case with external genital infection. All cases responded to the drug, and marked response was seen in 2 cases, moderate response in 6 cases. Neither side effects nor abnormal values in clinical laboratory findings attributable to the drug were seen.
Insights
A clinical study evaluated cefpiramide (CPM), a new cephalosporin antibiotic, in 8 patients with various gynecological infections. All patients responded positively to CPM treatment, with no observed side effects.
Area of Science:
- Pharmacology
- Infectious Diseases
- Antibiotic Therapy
Background:
- Cephalosporin antibiotics are crucial in treating bacterial infections.
- Cefpiramide (CPM) is a novel cephalosporin antibiotic investigated for its therapeutic potential.
- Gynecological infections pose significant health challenges, necessitating effective antimicrobial agents.
Observation:
- A clinical study administered intravenous cefpiramide (CPM) at a daily dose of 2g to 8 patients.
- Patient cohort included intrauterine infection, adnexitis, intrapelvic infection, and external genital infection cases.
- Treatment outcomes and clinical laboratory findings were monitored to assess CPM's safety and efficacy.
Findings:
- All 8 patients demonstrated a positive response to cefpiramide (CPM) treatment.
- Marked clinical improvement was observed in 2 patients, with moderate improvement in 6 patients.
- No adverse side effects or abnormal clinical laboratory values were attributed to cefpiramide (CPM).
Implications:
- Cefpiramide (CPM) shows promising efficacy and a favorable safety profile for treating gynecological infections.
- These findings support further investigation into cefpiramide's role in clinical antimicrobial strategies.
- The study highlights cefpiramide's potential as a valuable therapeutic option in managing complex bacterial infections.